News

Actavis has launched Finasteride in France, just one day before the patent expired. The distribution of the product has already been initiated. Finasteride Actavis was launched by the

CEL-SCI has filed a provisional US patent application covering its LEAPS immune therapy drugs (vaccines). It is intended for the prevention/treatment of H1N1, swine flu, bird flu, Influenza

Gentiva Health Services, a provider of comprehensive home health services, has acquired Mid-State Home Health in Louisiana. Tony Strange, President and CEO, Gentiva, said Combining forces with Mid-State

Cell Therapeutics (CTI) has completed the submission of New Drug Application (NDA) to the FDA for pixantrone. It is intended to treat relapsed or refractory, aggressive non-Hodgkin’ lymphoma

Conatus Pharmaceuticals (Conatus) has initiated the second phase-II clinical trial with a drug candidate, for the treatment of liver disease associated with Hepatitis C Virus (HCV) infection. The

Takeda has completed the acquisition of IDM Pharma for $2.64 per share in cash, through a short-form merger of Jade, a wholly-owned subsidiary of Takeda, into IDM. With

OncoGenex has signed an agreement with FDA via the special protocol assessment process (SPA), on an amendment to the design of a phase-III registration trial of OGX-011. It

Matrixx has said that it is in the process of formally notifying retailers, wholesalers and distributors nationwide, of its recall of all Zicam Cold Remedy Nasal Gel and

Acusphere has cancelled Cephalon’s $15 million Senior Secured Convertible Note. It has amended March and November 2008 License Agreements with Cephalon, for the oncology applications of Acusphere’s Hydrophobic